1. Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME). (14th November 2014) Authors: Chalmers, J.R.; Schmitt, J.; Apfelbacher, C.; Dohil, M.; Eichenfield, L.F.; Simpson, E.L.; Singh, J.; Spuls, P.; Thomas, K.S.; Admani, S.; Aoki, V.; Ardeleanu, M.; Barbarot, S.; Berger, T.; Bergman, J.N.; Block, J.; Borok, N.; Burton, T.; Chamlin, S.L.; Deckert, S. Journal: British journal of dermatology Issue: Volume 171:Number 6(2014:Dec.) Page Start: 1318 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME). (1st December 2014) Authors: Chalmers, J.R.; Schmitt, J.; Apfelbacher, C.; Dohil, M.; Eichenfield, L.F.; Simpson, E.L.; Singh, J.; Spuls, P.; Thomas, K.S.; Admani, S.; Aoki, V.; Ardeleanu, M.; Barbarot, S.; Berger, T.; Bergman, J.N.; Block, J.; Borok, N.; Burton, T.; Chamlin, S.L.; Deckert, S. Journal: British journal of dermatology Issue: Volume 171:Number 6(2014:Dec.) Page Start: 1318 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Use of an alternative method to evaluate erythema severity in a clinical trial: difference in vehicle response with evaluation of baseline and postdose photographs for effect of oxymetazoline cream 1·0% for persistent erythema of rosacea in a phase IV study. (27th February 2019) Authors: Eichenfield, L.F.; Del Rosso, J.Q.; Tan, J.K.L.; Hebert, A.A.; Webster, G.F.; Harper, J.; Baldwin, H.E.; Kircik, L.H.; Stein‐Gold, L.; Kaoukhov, A.; Alvandi, N. Journal: British journal of dermatology Issue: Volume 180:Number 5(2019) Page Start: 1050 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Use of an alternative method to evaluate erythema severity in a clinical trial: difference in vehicle response with evaluation of baseline and postdose photographs for effect of oxymetazoline cream 1·0% for persistent erythema of rosacea in a phase IV study. (1st May 2019) Authors: Eichenfield, L.F.; Del Rosso, J.Q.; Tan, J.K.L.; Hebert, A.A.; Webster, G.F.; Harper, J.; Baldwin, H.E.; Kircik, L.H.; Stein‐Gold, L.; Kaoukhov, A.; Alvandi, N. Journal: British journal of dermatology Issue: Volume 180:Number 5(2019) Page Start: 1050 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗